353 results on '"Pokrovsky, Vadim"'
Search Results
2. Sphingolipid Metabolism in Tumor Cells
3. Targeting Methionine Addiction of Cancer Cells with Methioninase
4. Physiologically based pharmacokinetic model for predicting the biodistribution of albumin nanoparticles after induction and recovery from acute lung injury
5. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials
6. Technological aspects of manufacturing and analytical control of biological nanoparticles
7. Oxidative Stress and Redox-Dependent Signaling in Prostate Cancer
8. Synthesis and in vitro cytotoxicity of benzoxazole‐based PPARα/γ antagonists in colorectal cancer cell lines.
9. The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution.
10. PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation
11. Correction: Plyasova et al. Penetration into Cancer Cells via Clathrin-Dependent Mechanism Allows L-Asparaginase from Rhodospirillum rubrum to Inhibit Telomerase. Pharmaceuticals 2020, 13, 286
12. HIV-1 drug resistance among naïve patients in Armenia in 2017–2021
13. The potential of methioninase for cancer treatment
14. m6A Methylation in Regulation of Antiviral Innate Immunity
15. Saponin is Essential for the Isolation of Proteins and RNA from Biological Nanoparticles
16. Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy
17. Promising applications of steroid сonjugates for cancer research and treatment
18. Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
19. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial
20. Design, in silico studies, synthesis, and in vitro anticancer assessment of new naphthylidene isoxazolidinedione derivatives
21. Assessment of the effects of amphiphilic poly (N‑vinylpyrrolidone) nanoparticles loaded with bortezomib on glioblastoma cell lines and zebrafish embryos
22. 3,4-Diarylisoxazoles─Analogues of Combretastatin A-4: Design, Synthesis, and Biological Evaluation In Vitro and In Vivo
23. Human Metastatic Melanoma Cell Lines Panel for In Vitro and In Vivo Investigations
24. PC Kz is the novel human prostate cancer model in vitro and in vivo
25. Cytotoxic and Anticancer Activity of Pharmacological Pairs of C115H Methionine–Gamma-lyase and S-Propyl-L-Cysteine Sulfoxide
26. [3+2]-Cycloaddition of Nitrile Imines to Parabanic Acid Derivatives—An Approach to Novel Spiroimidazolidinediones
27. Toxicity Evaluation and Control Release of Curcumin-Loaded Amphiphilic Poly-n-vinylpyrrolidone Nanoparticles for the Treatment of Malignant Tumors: In Vitro and In Vivo Models
28. The use of L-asparaginase for the treatment of solid tumors: data from experimental studies and clinical trials
29. Swelling, Rupture and Endosomal Escape of Biological Nanoparticles Per Se and Those Fused with Liposomes in Acidic Environment.
30. m 6 A Methylation in Regulation of Antiviral Innate Immunity.
31. Antiproliferative activity of the novel CYP17A1 inhibitor alsevirone
32. Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment
33. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
34. Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
35. Upconversion Nanoparticles Intercalated in Large Polymer Micelles for Tumor Imaging and Chemo/Photothermal Therapy
36. Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
37. Design, in silicostudies, synthesis, and in vitroanticancer assessment of new naphthylidene isoxazolidinedione derivatives
38. [3+2]-Cycloaddition of Nitrile Imines to Parabanic Acid Derivatives—An Approach to Novel Spiroimidazolidinediones.
39. Toxicity Evaluation and Controlled-Release of Curcumin-Loaded Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles: In Vitro and In Vivo Models.
40. Expert consensus statement on the science of HIV in the context of criminal law
41. The Russian database of HIV antiretroviral drug resistance
42. Antitumor Effect of Bleomycin Nanoaerosol in Murine Carcinoma Model
43. HIV-1 Drug Resistance among Treatment-Naïve Patients in Russia: Analysis of the National Database, 2006–2022
44. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials
45. Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial
46. Synthesis and Biological Evaluation of Benzo [4,5]- and Naphtho[2′,1′:4,5]imidazo[1,2-c]pyrimidinone Derivatives.
47. Synthesis and Preclinical Evaluation of Small-Molecule Prostate-Specific Membrane Antigen-Targeted Abiraterone Conjugate
48. Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and Long-Term In Situ Imaging
49. Design and Synthesis of New Agents for Prostate Cancer Treatment Inspired by Steroidal CYP17 A1 Inhibitors
50. Predictive markers for efficiency of the amino-acid deprivation therapies in cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.